AAV-GAD gene for rat models of neuropathic pain and Parkinson's disease

Acta Neurochirurgica, Supplementum

Volumn , Issue 101, 2008, Pages 99-105

  Kim, J ^a   Yoon, Y S ^a   Lee, H ^b   Chang, Jin Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

adeno associated virus; Gene therapy; glutamate decarboxylase 65; neuropathic pain; parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; APOMORPHINE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CELL DEATH; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; DRUG EFFICACY; GENE EXPRESSION; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; RAT; REVIEW; SPINAL CORD DORSAL HORN; SPINAL CORD VENTRAL HORN; SPINAL GANGLION; SYMPTOM; SYNAPSE; SYNAPTIC INHIBITION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADENOVIRUS; ANIMAL; DISEASE MODEL; GENE THERAPY; GENETICS; HUMAN; METHODOLOGY; NEURALGIA; PHYSIOLOGY;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; GLUTAMATE DECARBOXYLASE; HUMANS; NEURALGIA; PARKINSON DISEASE; RATS;

EID: 85052610107     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-78205-7_17     Document Type: Review

References (50)

1. Alisky JM, Hughes SM, Sautcr SL, Jolly D, Dubensky TWJ, Staber PD (2000) Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Ncuroreport 11:2669-2673
2. Bohn MC, Choi-Lundberg DL, Davidson BL, Leranth C, Kozlowski DA, Smith JC (1999) Adenovirus-mediated transgene expression in nonhuman primate brain. Hum Gene Ther 10:1175-1184
3. Bridges D, Thompson SW, Rice AS (2001) Mechanisms of neuropathic pain. Br J Anaesth 87:12-26
4. Buning H, Nicklin SA, Perabo L, Hallek M, Baker AH (2003) AAV-based gene transfer. Curr Opin Mol Ther 5:367-375
5. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Willians P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N (2004) Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10:302-317
6. Burger C, Nash K, Mandel RJ (2005) Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 16:781-791
7. Cao L, Liu Y, During MJ, Xiao W (2000) High-titer, wild-type free recombinant adeno-associated virus vector production using introncontaining helper plasmids. J Virol 74:11456-11463
8. Chen H, McCarty DM, Bruce AT, Suzuki K (1998) Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adenoassociated virus. Gene Ther 5:50-58
9. Chen ZY, Yant SR, He CY, Meuse L, Shen S, Kay MA (2001) Linear DNAs concatcmcrizc in vivo and result in sustained transgene expression in mouse liver. Mol Ther 3:403-410
10. Couto LB, GF P (2003) AAV-mediated gene therapy for hemophilia. Curr Opin Mol Ther 5:517-523
11. Davidson BL, Stein CS, Hcth JA, Martins I, Kotin RM, Derksen TA (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 97:3428-3432
12. Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149-158
13. Duan D, Yue Y, Engelhardt JF (2003) Dual vector expansion of the recombinant AAV packaging capacity. Meth Mol Biol 219:29-51
14. Dunnett SB, Bjorklund A (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399: A32-A39
15. During MJ, Kaplitt MG, Stern MB, Eidelberg D (2001) Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 12:1589-1591
16. During MJ, Kaplitt MG, Stern MB, Eidelberg D (2001) Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 12:1589-1591
17. Eaton M, Blits B, Ruitenberg MJ, Verhaagen J, Oudega M (2002) Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther 9:1387-1395
18. Ericson C, Wictorin K, Lundberg C (2002) Ex vivo and in vitro studies of transgene expression in rat astrocytes transduced with lentiviral vectors. Exp Neurol 173:22-30
19. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylases. Neuron 7:91-100
20. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (Pt 5):2283-2301
21. Fleming J, Ginn SL, Weinberger RP, Trahair TN, Smythe JA, Alexander IE (2001) Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons. Hum Gene Ther 12:77-86
22. Gao G, Alvira MR, Somanathan S, Lu Y, Vandenberghe LH, Rux JJ (2003) Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci USA 100:6081-6086
23. Hao S, Mata M, Wolfe D, Glorioso JC, Fink DJ (2005) Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol 57:914-918
24. Hao S, Mata M, Wolfe D, Glorioso JC, Fink DJ (2005) Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol 57:914-918
25. Hornykiewicz O (2001) Chemical neuroanatomy of the basal ganglia-normal and in Parkinson's disease. J Chcm Ncuroanat 22:3-12
26. Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freesc A (2002) Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylasc gene (ASPA) to the human brain. Hum Gene Ther 13:1391-1412
27. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL (1994) Long-term gene expression and phenotypic correction using adino-associataed virus vectors in the mammalian brain. Nat Genet 8:148-154 (Pubitemid 24308362)
28. Keir SD, Miller J, Yu G (1997) Efficient gene transfer into primary and immortalized human fetal glial cells using adeno-associated virus vectors: establishment of a glial cell line with a functional CD4 receptor. J Neurovirol 3:322-330
29. Klein RL, Hamby ME, Gong Y (2002) Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 176:66-74
30. Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S, Roitberg BZ (1999) Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160:1-16
31. Kwon BK, Liu J, Lam C, Plunet W, Oschipok LW, Hauswirth W, Di Polo A, Blesch A, Tetzlaff W (2007) Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine 32:1164-1173
32. Lawlor PA, During MJ (2004) Gene therapy for Parkinsons disease. Expert Rev Mol Med 2004:1-18
33. Lee B, Kim J, Kim SJ, Lee H, Chang JW (2007) Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain. Biochem Biophys Res Commun 357:971-976
34. Lee B, Lee H, Nam YR, Oh JH, Cho YH, Chang JW (2005) Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. Gene Ther 12:1215-1222
35. Liu J, Wolfe D, Hao S, Huang S, Glorioso JC, Mata M, Fink DJ (2004) Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther 10:57-66
36. Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML (2002) Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 298:425-429
37. Mackie M, Hughes DI, Maxwell DJ, Tillakaratne NJ, Todd AJ (2003) Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience 119:461-472
38. Martin DL, AJ T. (2000) Mechanisms controlling GABA synthesis and degradation in the brain. In: GABA in the nervous system: the view at fifty years. Williams & Wilkins, Philadelphia, PA, USA
39. Mi J, Chattcrjee S, Wong KK, Forbes C, Lawless G, Tobin AJ (1999) Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines. J Neurosci Res 57:137-148
40. Moore K, Kohno T, Scholz J, Karchewski LA, CJ W (2001) Spinal disinhibition: a role in neuropathic pain? Neurosci News 4:5-10
41. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22:6724-6731
42. Muramatsu S, Wang L, Ikeguchi K, Fujimoto K, Nakano I, Ozawa K (2002) Recombinent adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality. J Neurol 249 Suppl 2:36-40
43. Robert JJ, Bouilleret V, Ridoux V, Valin A, Geoffroy MC, Mallet J (1997) Adenovirus-mediated transfer of a fuctional GAD gene into nerve cells: potential for the treatment of neurological diseases. Gene Ther 4:1237-1245
44. Soghomonian JJ, Martin DL (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19:500-505
45. Tian YY, Tang CJ, Wang JN, Feng Y, Chen XW, Wang L, Qiao X, Sun SG (2007) Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors. Neurosci Lett 421:239-244
46. Todd AJ, Maxwell DJ (2000) GABA in the mammalian spinal cord. In: Martin DL, Olscn RW (eds) GABA in the nervous systems: the view at fifty years
47. Wang L, Muramatsu S, Lu Y, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Hanazono Y, Kume A, Urano F, Ichinose H, Nagatsu T, Nakano I, Ozawa K (2002) Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther 9:381-389
48. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC (1999) Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 96:3211-3216
49. Wu P, Phillips MI, Bui J, Terwilliger EF (1998) Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J Virol 72:5919-5926
50. Xu Y, Gu Y, Wu P, Li GW, Huang LY (2003) Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum Gene Ther 14:897-906